TTK在肿瘤中的研究进展

doi:10.11904/j.issn.1002-3070.2021.02.017

Abstract

CLC Number:

R730.5

BI Jiaqing, QIN Qian, MA Huihan, MA Meijie, FENG Qinmei. Research progress of threonine and tyrosine kinase in tumor[J]. Journal of Practical Oncology, 2021, 35(2): 188-192.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/10.11904/j.issn.1002-3070.2021.02.017

http://journal09.magtechjournal.com/Jwk3_syzlxzz/EN/Y2021/V35/I2/188

1 林玉华,倪振华.SPDEF与恶性肿瘤关系的研究进展[J].实用肿瘤学杂志,2020,34(2):185-188.
2 曹毛毛,陈万青.中国恶性肿瘤流行情况及防控现状[J].中国肿瘤临床,2019,46(3):145-149.
3 Rutledge SD,Cimini D.Consequences of aneuploidy in sickness and in health[J].Curr Opin Cell Biol,2016,40:41-46.
4 Fisk HA,Mattison CP,Winey M.A field guide to the Mps1 family of protein kinases[J].Cell Cycle,2014,3(4):437-440.
5 Lara-Gonzalez P,Westhorpe FG,Taylor SS.The spindle assembly checkpoint[J].Curr Biol,2012,22(22):966-980.
6 Lauzé E,Stoelcker B,Luca FC,et al.Yeast spindle pole body duplication gene Mps1 encodes an essential dual specificity protein kinase[J].EMBO J,1995,14(8):1655-1663.
7 Musacchio A.Spindle assembly checkpoint:the third decade[J].Phi Trans R Soc B,2011,366(1584):3595-3604.
8 Xie Y,Wang AQ,Lin JZ,et al.Mps1/TTK:a novel target and biomarker for cancer[J].J Drug Target,2017,25(2):112-118.
9 Stratford JK,Yan F,Hill RA,et al.Genetic and pharmacological inhibition of TTK impairs pancreatic cancer cell line growth by inducing lethal chromosomal instability[J].PLoS One,2017,12(4):e0174863.
10 Kaistha BP,Honstein T,Müller V,et al.Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells[J].Br J Cancer,2014,111(9):1780-1787.
11 Tang JN,Lu MX,Cui QX,et al.Overexpression of ASPM,CDC20,and TTK confer a poorer prognosis in breast cancer identified by gene co-expression network analysis[J].Front Oncol,2019,9:310.
12 Riggs JR,Nagy M,Elsner J,et al.The discovery of a dual TTK protein kinase/CDC2-like kinase(CLK2)inhibitor for the treatment of triple negative breast cancer initiated from a phenotypic screen[J].J Med Chem,2017,60(21):8989-9002.
13 King JL,Zhang BT,Li YX,et al.TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer[J].Oncogenesis,2018,7(9):69.
14 李倩,刘颖,郭君兰.红景天苷对人肺癌A549细胞裸鼠移植瘤生长的影响及对MAPK/ERK1/2信号通路的调控作用[J].中医学报,2020,35(7):1469-1476.
15 Chen XL,Yu CL,Gao J,et al.A novel USP9X substrate TTK contributes to tumorigenesis in non-small-cell lung cancer[J].Theranostics,2018,8(9):2348-2360.
16 Miao RY,Wu Y,Zhang HH,et al.Utility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancer[J].Sci Rep,2016,6:33121.
17 梁若飞,杨彬彬,唐晓平.EN2在胶质母细胞瘤中的表达及其预后价值[J].现代肿瘤医学,2020,28(16):2783-2786.
18 Tannous BA,Kerami M,Vanderstoop PM,et al.Effects of the selective Mps1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs[J].J Natl Cancer Inst,2013,105(17):1322-1331.
19 Maia ARR,de Man J,Boon U,et al.Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model[J].Ann Oncol,2015,26(10):2180-2192.
20 Argyriou AA,Koltzenburg M,Polychronopoulos P,et al.Peripheral nerve damage associated with administration of taxanes in patients with cancer[J].Crit Rev Oncol Hematol,2008,66(3):218-228.
21 Hilkens PH,Verweij J,Vecht CJ,et al.Clinical characteristics of severe peripheral neuropathy induced by docetaxel(Taxotere)[J].Ann Oncol,1997,8(2):187-190.
22 Wu ZX,Yang YQ,Wang GS,et al.Dual TTK/CLK2 inhibitor,CC-671,selectively antagonizes ABCG2-mediated multidrug resistance in lung cancer cells[J].Cancer Sci,2020,111(8):2872-2882.
23 Maachani UB,Kramp T,Hanson R,et al.Targeting Mps1 enhances radiosensitization of human glioblastoma by modulating DNA repair proteins[J].Mol Cancer Res,2015,13(5):852-862.
24 Chandler BC,Speers C.A novel role for TTK in homologous recombination:implications for breast cancer radiosensitivity[J].Mol Cell Oncol,2020,7(3):e1737771.
25 Chandler BC,Moubadder L,Ritter CL,et al.TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination[J].J Clin Invest,2020,130(2):958-973.
26 Bie L,Zhao G,Cheng P,et al.The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression[J].PLoS One,2011,6(10):e25631.
27 Wang J,Xie YC,Bai XB,et al.Targeting dual specificity protein kinase TTK attenuates tumorigenesis of glioblastoma[J].Oncotarget,2018,9(3):3081-3088.
28 Xu QQ,Xu YL,Pan B,et al.TTK is a favorable prognostic biomarker for triple-negative breast cancer survival[J].Oncotarget,2016,7(49):81815-81829.
29 Zhang J,Li D,Zhang YM,et al.Integrative analysis of mRNA and miRNA expression profiles reveals seven potential diagnostic biomarkers for non-small cell lung cancer[J].Oncol Rep,2020,43(1):99-112.
30 Zheng L,Chen Zb,Kawakami M,et al.Tyrosine threonine kinase inhibition eliminates lung cancers by augmenting apoptosis and polyploidy[J].Mol Cancer Ther,2019,18(10):1775-1786.
31 Tsai YM,Wu KL,Chang YY,et al.Upregulation of Thr/Tyr kinase increases the cancer progression by neurotensin and dihydropyrimidinase-Like 3 in lung cancer[J].Int J Mol Sci,2020,21(5):1640.
32 Du LQ,Zhao ZZ,Suraokar M,et al.LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer[J].Oncotarget,2018,9(51):29601-29618.
33 Kang T,Yan JH,Bao H,et al.Expression and clinical significance of TTK in cervical cancer[J].Int J Clin Exp Med,2018,11(11):12133-12140.
34 Guo Y,Zhang XJ,Xu QB,et al.Human papillomavirus 16 oncoprotein E7 retards mitotic progression by blocking Mps1-MAP4 signaling cascade[J].Oncogene,2019,38(31):5959-5970.
35 Chen F,Wu PK,Hu HL,et al.Protein kinase TTK promotes proliferation and migration and mediates epithelial-mesenchymal transition in human bladder cancer cells[J].Int J Clin Exp Pathol,2018,11(10):4854-4861.
36 Liu XD,Yao DW,Xin F.TTK contributes to tumor growth and metastasis of clear cell renal cell carcinoma by inducing cell proliferation and invasion[J].Neoplasma,2019,66(6):946-953.
37 Kusakabe K,Ide N,Daigo Y,et al.Discovery of imidazo[1,2-b]pyridazine derivatives:selective and orally available Mps1(TTK)kinase inhibitors exhibiting remarkable antiproliferative activity[J].J Med Chem,2015,58(4):1760-1775.
38 Tardif KD,Rogers A,Cassiano J,et al.Characterization of the cellular and antitumor effects of MPI-0479605,a small-molecule inhibitor of the mitotic kinase Mps1[J].Mol Cancer Ther,2011,10(12):2267-2275.
39 Feng H,Gu ZY,Li Q,et al.Identification of significant genes with poor prognosis in ovarian cancer via bioinformatical analysis[J].J Ovarian Res,2019,12(1):35.
40 Singh R,Som A.Identification of common candidate genes and pathways for progression of ovarian,cervical and endometrial cancers[J].Meta Gene,2020,23:100634.
41 Alberto O,Javier PP,Ana AS,et al.In silico analyses identify gene-sets,associated with clinical outcome in ovarian cancer:role of mitotic kinases[J].Oncotarget,2016,7(16):22865-22872.

[1]	WANG Jianyu, ZHANG Xianyu, PANG Da. Influencing factors of neoadjuvant chemotherapy for Luminal A type breast cancer [J]. Journal of Practical Oncology, 2021, 35(2): 131-136.
[2]	WU Zhe, PANG Ya, MING Zhi, LIU Ke, WANG Dong, YAN Jun. Application of artificial intelligence technology in automatic delineation of organs at risk in nasopharyngeal carcinoma radiotherapy [J]. Journal of Practical Oncology, 2021, 35(2): 137-141.
[3]	WANG Mengmeng, LIAN Jie, LI Hengzhen, ZHANG Yanqiao. Research progress in immunotherapy of gastrointestinal pancreatic neuroendocrine tumors [J]. Journal of Practical Oncology, 2021, 35(2): 154-159.
[4]	LI Hui, PANG Da. The role of m6A methylation modification in tumors [J]. Journal of Practical Oncology, 2020, 34(5): 480-484.
[5]	LI Guozheng, PANG Da. Progression in the treatment of HER2-positive breast cancer [J]. Journal of Practical Oncology, 2020, 34(1): 74-78.
[6]	CHEN Hongbo, YU Zengrong, DING Xiaofan, XIAO Lin. Progress of correlation between bone marrow dose-volume parameters and acute hematologic toxicity in pelvic malignant tumor [J]. Journal of Practical Oncology, 2019, 33(4): 361-366.
[7]	XU Bing, HUANG Suqin, WU Linlan, WEI Jianwei, YANG Xiaomei, ZHAO Zhiping, CHEN Yi, JIANG Xiaozhi. Therapeutic effect of sequential local injection of heterogeneic lymphocytes and autologus lymphocytes on transplanted hepatocarcinoma in mice [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 493-497.
[8]	ZHANG Xialan, SHEN Xikun, HUANG Yuyu. Application of nutritional status screening in advanced cancer patients by nutrition risk screening 2002 [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 229-233.
[9]	ZHOU Jie, CHEN Yu, CHEN Daozhen. Application of nanoparticles in photodynamic therapy of tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 245-249.
[10]	MA Chao, WANG Guonian. Effects of anesthetics on immune function in perioperative cancer patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 285-288.
[11]	DU Yesheng, HU Songliu, XU Xiangying. Study of oligodendrocyte metastasis in non-small cell lung cancer by stereotactic radiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 154-158.
[12]	LIU Guohui, GU Anxin, YIN Hongtao, CAO Yang, HE Yunlong, WANG Chunbo, E Mingyan. Protosappanin A increases the sensitivity of gastric cancer SGC-7901 cells to radiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 500-505.
[13]	HUANG Qianqian, MA Jianjia, WU Qiang, LIU Binbin, MU Xiaoqin, LIU Shulin. Research progress on tumor stem cells and tumor targeted therapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 533-537.
[14]	LIANG Yusi, TAN Yonggang, ZOU Huawei. Research progress on mechanism of low-dose chemotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 538-542.
[15]	GUO Qing,HU Shanshan,YAN Gaowu,DU Yong. Research progress of microwave ablation in the treatment of hapatic tumor [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(3): 268-271.

Research progress of threonine and tyrosine kinase in tumor

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments